LW was doing some general portfolio trimming (read dumping) earlier this year. It was across the board. This is worth $1b upon a successful Phase 3 and NDA with FDA. Very attractive risk v reward vs most biotechs which are many years away from actual commercialisation and have to raise $50m + to get there. Not long to wait now and I am encouraged now that the anecdotal feedback from trial (lav and lilac) echoes what was coming out during phase 2a and b. Just need to hope results are consistent with some of that caregiver feedback.
******, page-20
-
- There are more pages in this discussion • 64 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.24 |
Change
0.890(6.20%) |
Mkt cap ! $1.927B | |||
| Open | High | Low | Value | Volume |
| $14.35 | $15.27 | $14.35 | $6.555M | 437.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 1882 | $16.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.04 | 188 | 1 |
View Market Depth
| Last trade - 15.59pm 27/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |